HSPA5 and nasopharyngeal carcinoma: Particularly, GRP78 was validated to be a promising target for Hotair and an anti-cancer molecular target in NPC cells by using loss-of-function and gain-of-function studies, suggesting that it might be a novel molecular target of Hotair in NPC.